Dogwood Therapeutics (DWTX) Other Operating Expenses (2026)

Dogwood Therapeutics has reported Other Operating Expenses for 1 years, with the latest figure at $9.2 million in Q2 2026.

• On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $9.2 million in Q2 2026; TTM through Jun 2026 was $9.2 million, a N/A change from a year earlier, with the FY2025 full-year figure at -$2731.0, changed N/A from the prior year.
• Other Operating Expenses was $9.2 million for Q2 2026 at Dogwood Therapeutics.
• The five-year high for Other Operating Expenses was $9.2 million in Q2 2026, with the low at $9.2 million in Q2 2026.